A Powerful Natural Antioxidant for Health and Beauty

Alpha Lipoic Acid Help for Advanced and Chronic Kidney Disease

words including: chronic, kidney, calcitriol, maintaining, progressive, process, chronic, dialysis, artificial, functions, renal disease, calcium, transplant, phosphorus

Clinical studies suggest that alpha lipoic acid may help prevent and treat kidney disease. Not only can alpha lipoic acid prevent kidney cell damage caused by toxins or kidney disease itself, it also protects other organs from the effects of the condition: (iv.143)

  • Atherosclerosis in the kidney's blood vessels causes renal failure. In clinical studies, alpha lipoic acid has been shown to reduce the risks of atherosclerosis. (iv.335189)
  • Research suggests alpha lipoic acid's anti-inflammatory and antioxidant properties could prevent damage in kidneys caused by angiotensin II. Alpha lipoic acid suppressed inflammatory proteins while stimulating levels of natural antioxidants in rats that express chronic levels of this hormone. (iv.102140)
  • Prevents chemotherapy-induced kidney damage. (iv.13)
  • Help reduce risk of heart disease in advanced kidney disease. (iv.108)
  • Could reduce calcification and cell damage in chronic kidney disease. (iv.141)
  • May help prevent free radical damage and counteract suppressed antioxidant levels in the brain caused by toxic cyanate and cyanide levels in patients with chronic kidney failure. (iv.142)

Clinical Evidence of Alpha Lipoic Acid Benefits

Table IV.16: Clinical Evidence of Alpha Lipoic Acid's Benefits in Kidney Disease
Study Details Alpha Lipoic Acid Form/Dosage and/or Drug Combination
Randomized, controlled clinical trial. (iv.143) 600 mg/day of oral alpha lipoic acid along with regular blood pressure and diabetes medications (including insulin) for 18 months. (iv.143)
Patients TAKE AWAY POINT

84 adult patients with type 1 or type 2 diabetes: (iv.143)

  • 35 were assigned to take alpha lipoic acid (20 with type 1 and 15 with type 2 diabetes).
  • 49 served as control group (34 with type 1 and 15 with type 2 diabetes).
Alpha lipoic acid could help prevent the development or progression of kidney disease (diabetic nephropathy) in patients with diabetes(iv.143)
Outcomes
Research suggests that alpha lipoic acid may help prevent and treat kidney disease.
  • Albuminuria by almost 50%. (iv.143)
  • Thrombomodulin in the blood by almost 18%. (iv.143)

Also known as proteinuria, albuminuria is a condition of high protein levels in urine. Kidney disease is a known cause of albuminuria. Thrombomodulin is a protein found on the membranes of cells that line blood vessels (endothelial cells). It's also found in the blood. (iv.33144)

On the cell surface thrombomodulin acts as an anticoagulant and anti-inflammatory molecule. The amount of thrombomodulin shed by endothelial cells in the blood is often measured as plasma or soluble thrombomodulin levels. Normal levels can differ depending on race, gender, and even stage of life. (iv.144)

However, high levels of thrombomodulin in the blood are a sign of dysfunctional or injured endothelial cells caused by inflammation and free radicals. It's an indicator of disease severity, duration, and progression in diabetes, cirrhosis of the liver, atherosclerosis, diabetic kidney disease and retinopathy, and even multiple sclerosis. The reduced levels of thrombomodulin found in patients who took alpha lipoic acid suggest that alpha lipoic acid can help protect against the cell damage caused by diabetes. (iv.143-144)

 
Study Details Alpha Lipoic Acid Form/Dosage and/or Drug Combination
Randomized, double-blinded, placebo-controlled clinical trial. (iv.108) 600 mg/day of oral alpha lipoic acid for 8 weeks. (iv.108)
Patients TAKE AWAY POINT

63 male and female adult patients with end-stage renal disease: (iv.108)

  • 31 were assigned to take alpha lipoic acid (20 with type 1 and 15 with type 2 diabetes).
  • 32 served as control group and received a placebo.
Alpha lipoic acid could help prevent the development of heart disease in patients with advanced kidney disease. (iv.108)
Outcomes
  • HsCRP levels by almost 18.7%. (iv.108)
  • HDL cholesterol levels significantly (but not statistically significant compared to those who took the placebo). (iv.108)

HsCRP is an inflammatory risk factor for cardiovascular disease(iv.108)

Recommended Dosage

Integrative experts suggest doses of 600-1200 mg/day of alpha lipoic acid could help prevent diabetic complications such as kidney disease. Divide dosages evenly and take the divided doses 3 times a day. (iv.70)

From excess urea in the blood; can lead to stroke and neurodegenerative diseases(iv.142)
A study where neither the researcher nor the subject/patient knows who is receiving the placebo and who is receiving the tested substance. (iv.33)
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information presented on this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.